Prognostic Value of Restaging FDG-PET/CT for Detecting Recurrence in Patients with Malignant Cutaneous Melanoma

被引：0
|
作者：
Contreras Ameduri, M. [1 ]
Noriega-Alvarez, E. [1 ]
Sicilia Pozo, M. [1 ]
Lucas Lucas, C. [1 ]
Padilla Bermejo, A. [1 ]
Cruz Montijano, M. [2 ]
Garcia Zoghby, L. [2 ]
Pena Pardo, F. [1 ]
Talavera Rubio, M. [1 ]
Garcia Vicente, A. [2 ]
Soriano Castrejon, A. [2 ]
Garcia Poblete, V. [1 ]
机构：
[1] Hosp Gen Univ Ciudad Real, Serv Med Nucl, Ciudad Real, Spain
[2] Hosp Univ Toledo, Serv Med Nucl, Toledo, Spain
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2023年 / 50卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EPS-268
引用
收藏
页码：S392 / S392
页数：1
相关论文
共 50 条
  • [31] Should FDG-PET/CT be the first line imaging modality for restaging and/or evaluation of recurrence in patients with ovarian cancer?
    Sanli, Yasemin
    Turkmen, Cuneyt
    Mudun, Ayse
    Adalet, Isik
    Unal, Seher
    Bakir, Baris
    Topuz, Samet
    Iyibozkurt, Cem
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51
  • [32] Diagnostic accuracy of contrast-enhanced FDG-PET/CT in primary staging of cutaneous malignant melanoma
    Patrick Veit-Haibach
    Florian M. Vogt
    Robert Jablonka
    Hilmar Kuehl
    Andreas Bockisch
    Thomas Beyer
    Gerlinde Dahmen
    Sandra Rosenbaum
    Gerald Antoch
    European Journal of Nuclear Medicine and Molecular Imaging, 2009, 36
  • [33] Diagnostic accuracy of contrast-enhanced FDG-PET/CT in primary staging of cutaneous malignant melanoma
    Veit-Haibach, Patrick
    Vogt, Florian M.
    Jablonka, Robert
    Kuehl, Hilmar
    Bockisch, Andreas
    Beyer, Thomas
    Dahmen, Gerlinde
    Rosenbaum, Sandra
    Antoch, Gerald
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 (06) : 910 - 918
  • [34] FDG PET/CT for Staging and Restaging Malignant Mesothelioma
    Lopci, Egesta
    Castello, Angelo
    Mansi, Luigi
    SEMINARS IN NUCLEAR MEDICINE, 2022, 52 (06) : 806 - 815
  • [35] Prognostic value of staging 18FDG PET/CT in patients with malignant melanoma in correlation with Clarke level
    Santha, O.
    Varga, J.
    Olajos, J.
    Garai, I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S385 - S385
  • [36] The role of [18F]FDG-PET/CT in the restaging of patients with colorectal cancer: a comparison with CT and biochemical markers of recurrence
    Locantore, L.
    Volterrani, D.
    Erba, P.
    Mariani, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S370 - S370
  • [37] Value of PET-CT using FDG in Restaging Plasmacytoma patients
    Filmont, J. E.
    Toubert, M. E.
    Fermand, J. P.
    Rain, J. D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S152 - S152
  • [38] Whole body FDG-PET/CT in restaging of lymphoma.
    Freudenberg, LS
    Antoch, G
    Mueller, SP
    Goerges, R
    Bockisch, A
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 83P - 84P
  • [39] The prognostic value of FDG-PET imaging in malignant pleural mesothelioma.
    Bénard, F
    Alavi, A
    Sterman, D
    Shnier, D
    Smith, RJ
    JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (05) : 81P - 81P
  • [40] THE CLINICAL IMPACT OF FDG PET/CT IN THE ASSESSMENT OF CUTANEOUS MALIGNANT MELANOMA
    Wong, F.
    INTERNAL MEDICINE JOURNAL, 2011, 41 : 18 - 18
12345